PRODUCT DATASHEET · DC53130
93-O17S
Version 1.b2bde399 · 2026-09-13
| CAS No. | Not available |
| Chemical Name | 93-O17S |
| Synonyms | 93O17S, 93 O17S |
| SMILES | O=C(CCN(CCC(OCCSCCCCCCCCCCCCCC)=O)CCCN1C=NC=C1)OCCSCCCCCCCCCCCCCC |
| Formula | C44H83N3O4S2 |
| M.Wt | 782.3 |
| Purity | ELSD-HPLC>95% |
| Storage | Original product: up to 1 year under the storage conditions stated on the vial, kept tightly sealed. Stock solutions: aliquots at -20°C, generally up to one month. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | 1. Li, Y., Yang, T., Yu, Y., et al. Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins. Biomaterials 178, 652-662 (2018). 2. Chen, J., Qiu, M., Ye, Z., et al. In situ cancer vaccination using lipi |
93-O17S is an imidazole-based synthetic lipidoid for in vivo mRNA delivery. Lipid nanoparticles (LNPs) with 93-O17S promotes both the cross-presentation of tumor antigens and the intracellular delivery of cGAMP (STING agonist).
Specifications shown are product-page values, not batch test results.
Read Instructions for Use →